Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $48.19M.
ENTERPRISE VALUE (EV)
$48.19M
eXoZymes, Inc.
Market Cap
$51.23M
Enterprise Value (EV)
$48.19M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.23M | $48.19M |
| INmune Bio, Inc. (INMB)vs › | $51.71M | $34.70M |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | $32.91M |
| biote Corp. (BTMD)vs › | $50.67M | $168.14M |
| Apollomics, Inc. (APLM)vs › | $50.51M | $47.88M |
| Celularity Inc. (CELU)vs › | $50.37M | $110.30M |
| Clene Inc. (CLNN)vs › | $49.84M | $62.51M |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | $43.32M |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $53.99M | $27.57M |
Market Cap
$51.23M
Total Debt
$0.00
Cash
$3.04M
Enterprise Value
$48.19M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
